Integrated Biopharma OTC Stock Forecast - Simple Moving Average
| INBPDelisted Stock | USD 0.23 0.01 4.55% |
The Simple Moving Average forecasted value of Integrated Biopharma on the next trading day is expected to be 0.23 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.49. Integrated OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Integrated Biopharma stock prices and determine the direction of Integrated Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Integrated Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Integrated |
Most investors in Integrated Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Integrated Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Integrated Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
A two period moving average forecast for Integrated Biopharma is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility. Integrated Biopharma Simple Moving Average Price Forecast For the 24th of April
Given 90 days horizon, the Simple Moving Average forecasted value of Integrated Biopharma on the next trading day is expected to be 0.23 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0002, and the sum of the absolute errors of 0.49.Please note that although there have been many attempts to predict Integrated OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Integrated Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Integrated Biopharma OTC Stock Forecast Pattern
| Backtest Integrated Biopharma | Integrated Biopharma Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Integrated Biopharma otc stock data series using in forecasting. Note that when a statistical model is used to represent Integrated Biopharma otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 105.7318 |
| Bias | Arithmetic mean of the errors | 0.001 |
| MAD | Mean absolute deviation | 0.0083 |
| MAPE | Mean absolute percentage error | 0.0351 |
| SAE | Sum of the absolute errors | 0.49 |
Predictive Modules for Integrated Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Integrated Biopharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integrated Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Integrated Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integrated Biopharma otc stock to make a market-neutral strategy. Peer analysis of Integrated Biopharma could also be used in its relative valuation, which is a method of valuing Integrated Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Integrated Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Integrated Biopharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Biopharma shares will generate the highest return on investment. By undertsting and applying Integrated Biopharma otc stock market strength indicators, traders can identify Integrated Biopharma entry and exit signals to maximize returns.
Integrated Biopharma Risk Indicators
The analysis of Integrated Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Integrated Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting integrated otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.85 | |||
| Standard Deviation | 5.22 | |||
| Variance | 27.26 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |